Takeda to fund Shire purchase with cash, cancels credit deal
Shire Plc
4,690.00p
16:39 08/01/19
Takeda Pharmaceutical Company announced on Friday that it intended to fund the cash consideration due on completion of the proposed acquisition of Shire from its cash resources and other financing sources.
FTSE 100
8,139.83
17:09 26/04/24
FTSE 350
4,470.09
16:59 26/04/24
FTSE All-Share
4,423.59
17:14 26/04/24
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
The Japanese pharmaceuticals giant said that as a result, it had cancelled in full the remaining commitments under the 364-day bridge credit agreement, which it entered into in connection with the acquisition on 8 May.
“In addition, certain technical amendments are being made to the term loan credit agreement dated 8 June, the senior short-term loan facility agreement dated 26 October, and the loan agreement with the Japan Bank for International Cooperation dated 3 December entered into by Takeda,” the firm’s board said in its statement.